ChemoCentryx Inc

NASDAQ:CCXI   3:59:50 PM EDT
50.83
+0.11 (+0.22%)
Mergers / Acquisitions

Amgen To Acquire ChemoCentryx For $4 Billion In Cash

Published: 08/04/2022 13:06 GMT
ChemoCentryx Inc (CCXI) - Amgen to Acquire Chemocentryx for $4 Billion in Cash.
Chemocentryx Inc - Amgen Will Acquire Chemocentryx for $52 per Share in Cash, Representing an Enterprise Value of Approximately $3.7 Billion.
Chemocentryx Inc - Acquisition Includes Tavneos(®) (avacopan), a First-in-class Medicine for Patients With Serious Autoimmune Disease.